EGFR and lung adenocarcinoma: EGFR mutation is the most common genetic alteration in East Asian lung adenocarcinoma patients [14,16]; hence, the survival benefits of mutation-targeted treatment in this group were mainly driven by the EGFR mutation and EGFR-TKI treatment.